|Articles|March 10, 2022
Identification of Insulin Oligomeric States v2
Author(s)Wyatt Technology
SEC-MALS identifies monomers, dimers, hexamers and higher aggregates of insulin to determine optimal formulation, storage and administration conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
Speed-to-IND Starts with Toxicology: A Rapid-Fire Q&A with Lonza
4
Ivonescimab Breakthrough Designation Highlights Progress in BTC Treatment
5